Trial Profile
Phase Ib Study of the Combination of BKM120 and Cisplatin or Carboplatin in Patients With Advanced Solid Tumors
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 27 Jun 2018
Price :
$35
*
At a glance
- Drugs Buparlisib (Primary) ; Carboplatin; Cisplatin
- Indications Solid tumours
- Focus Adverse reactions
- 18 Jun 2018 Status changed from active, no longer recruiting to completed.
- 07 Apr 2016 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 08 Oct 2015 New trial record